It is ironic that the most advanced creature on earth is controlled by a fist-sized pumping device (read organ!). And this highly complex component of the human body is also one of the most vulnerable organs. Minute changes in the mechanical sequence of the chambers (auricles & ventricles) can often be life-taking. Cardiac Resynchronization Therapy (CRT) is the aspect of science that deals with this particular functional imbalance. Cardiologists constantly face the challenge of monitoring the condition of the patient's heart, the pacemaker in particular. However, the launch of the world's first CRT defibrillator device will make this process a lot simpler. The Consulta CRT-D, developed by U.S. company Medtronic Inc., will now enable doctors to communicate with the pacemaker via a phone line. The first patient to have this device implanted is Monique Pachalek from the German Heart Institute Berlin (DHZB) on April 23, 2008. From the looks of it, this device would certainly make a huge difference to CRT, thus making a cardiologist's task easier and life-saving a breeze.